Cell Point (India) Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 1/6
Cell Point (India) has been growing earnings at an average annual rate of 6.5%, while the Specialty Retail industry saw earnings growing at 31.6% annually. Revenues have been growing at an average rate of 3.9% per year. Cell Point (India)'s return on equity is 0.3%, and it has net margins of 0.07%.
Wichtige Informationen
6.5%
Wachstumsrate der Gewinne
3.8%
EPS-Wachstumsrate
Specialty Retail Wachstum der Industrie | 27.4% |
Wachstumsrate der Einnahmen | 3.9% |
Eigenkapitalrendite | 0.3% |
Netto-Marge | 0.07% |
Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Aufschlüsselung der Einnahmen und Ausgaben
Wie Cell Point (India) Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Sep 24 | 3,168 | 2 | 222 | 0 |
30 Jun 24 | 3,190 | 10 | 220 | 0 |
31 Mar 24 | 3,212 | 17 | 218 | 0 |
31 Dec 23 | 3,130 | 31 | 209 | 0 |
30 Sep 23 | 3,048 | 45 | 199 | 0 |
30 Jun 23 | 3,002 | 56 | 196 | 0 |
31 Mar 23 | 2,957 | 67 | 194 | 0 |
31 Mar 22 | 2,692 | 16 | 189 | 0 |
31 Mar 21 | 2,230 | 7 | 155 | 0 |
31 Mar 20 | 2,776 | 16 | 192 | 0 |
Qualität der Erträge: CELLPOINT has a high level of non-cash earnings.
Wachsende Gewinnspanne: CELLPOINT's current net profit margins (0.07%) are lower than last year (1.5%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: CELLPOINT's earnings have grown by 6.5% per year over the past 5 years.
Beschleunigtes Wachstum: CELLPOINT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: CELLPOINT had negative earnings growth (-94.9%) over the past year, making it difficult to compare to the Specialty Retail industry average (32.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: CELLPOINT's Return on Equity (0.3%) is considered low.